Case 49: Theranostics for Brain Tumors

Publication date

2025

Authors

Tolboom, N.ORCID 0000-0002-8005-2833
Snijders, T. J.ORCID 0000-0003-0857-081XISNI 000000039373112X
van der Schaaf, Irene CISNI 0000000390429582
Braat, A. J.A.T.ORCID 0000-0002-8824-8697

Editors

Advisors

Supervisors

Document Type

Part of book

Collections

Open Access logo

License

taverne

Abstract

Meningiomas are frequently encountered primary brain tumors. Surgery can be curative but there is risk for recurrence. In addition, certain tumor localizations can make surgery challenging or impossible. Radiotherapy is meaningful for certain cases, but still recurrences occur. Peptide receptor radionuclide therapy (PRRT) is a promising treatment for treatment refractory/ unresectable meningioma. An intra-arterial approach for administering PRRT to obtain high tumor dosages is feasible, without additional toxicity. Here we present a case of a patient with progressive recurrence of a meningioma, treated with intra-arterial PRRT.

Keywords

Intra-arterial, Meningiona, PRRT, Theranostic, Taverne, General Medicine, General Neuroscience

Citation

Tolboom, N, Snijders, T J, Van der Schaaf, I C & Braat, A J A T 2025, Case 49 : Theranostics for Brain Tumors. in Coresource 4. Springer Nature, pp. 241-245. https://doi.org/10.1007/978-3-032-00522-9_49